Amdocs (NASDAQ:DOX – Get Free Report) issued an update on its second quarter 2024 earnings guidance on Tuesday morning. The company provided EPS guidance of 1.530-1.590 for the period, compared to the consensus EPS estimate of 1.600. The company issued revenue guidance of $1.2 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion. […]
Amdocs (NASDAQ:DOX – Get Free Report) updated its FY24 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of ~$6.38-6.62 for the period, compared to the consensus estimate of $6.51. The company issued revenue guidance of ~$4.94-5.14 billion, compared to the consensus revenue estimate of $5.05 billion. Amdocs also updated its FY […]
Amdocs (NASDAQ:DOX – Get Free Report) issued an update on its second quarter earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $1.53-1.59 for the period, compared to the consensus estimate of $1.60. The company issued revenue guidance of $1.225-1.265 billion, compared to the consensus revenue estimate of $1.25 billion. […]
Weil Company Inc. trimmed its stake in shares of Amdocs Limited (NASDAQ:DOX – Free Report) by 34.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,970 shares of the technology company’s stock after selling 4,817 shares during the period. […]